IRIS
ARTESE, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.225
AS - Asia 2.136
EU - Europa 1.269
SA - Sud America 367
Continente sconosciuto - Info sul continente non disponibili 111
AF - Africa 58
OC - Oceania 4
Totale 8.170
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.029
SG - Singapore 966
IT - Italia 588
CN - Cina 581
BR - Brasile 275
IN - India 201
DE - Germania 184
VN - Vietnam 182
GB - Regno Unito 118
CA - Canada 102
FI - Finlandia 94
SE - Svezia 83
UA - Ucraina 54
HK - Hong Kong 50
AR - Argentina 43
BD - Bangladesh 27
ES - Italia 24
NL - Olanda 22
EE - Estonia 20
IQ - Iraq 19
ID - Indonesia 18
MX - Messico 18
FR - Francia 17
ZA - Sudafrica 17
RU - Federazione Russa 16
IL - Israele 15
JP - Giappone 14
GT - Guatemala 13
CO - Colombia 12
SV - El Salvador 12
CR - Costa Rica 11
EC - Ecuador 10
EG - Egitto 10
SC - Seychelles 10
TR - Turchia 10
PL - Polonia 8
TT - Trinidad e Tobago 8
VE - Venezuela 8
CZ - Repubblica Ceca 7
HN - Honduras 7
LT - Lituania 7
PR - Porto Rico 7
DZ - Algeria 6
UY - Uruguay 6
CW - ???statistics.table.value.countryCode.CW??? 5
EU - Europa 5
JO - Giordania 5
MA - Marocco 5
CL - Cile 4
DO - Repubblica Dominicana 4
GP - Guadalupe 4
IR - Iran 4
KZ - Kazakistan 4
NI - Nicaragua 4
PE - Perù 4
PK - Pakistan 4
SA - Arabia Saudita 4
TW - Taiwan 4
AL - Albania 3
AM - Armenia 3
KE - Kenya 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AF - Afghanistan, Repubblica islamica di 2
AT - Austria 2
CY - Cipro 2
DK - Danimarca 2
ET - Etiopia 2
HR - Croazia 2
IE - Irlanda 2
JM - Giamaica 2
MD - Moldavia 2
MN - Mongolia 2
MY - Malesia 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
RO - Romania 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
UZ - Uzbekistan 2
AU - Australia 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CU - Cuba 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
IS - Islanda 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
LB - Libano 1
LU - Lussemburgo 1
Totale 8.061
Salva come PNG Salva come JPEG
Città #
San Jose 804
Dallas 560
Ashburn 399
Chandler 336
Singapore 255
Santa Clara 183
Munich 152
Council Bluffs 149
Hefei 143
Bengaluru 142
Milan 141
Princeton 126
Lawrence 124
Beijing 86
Ho Chi Minh City 76
London 76
Wilmington 70
Chicago 65
Helsinki 56
Ottawa 55
Los Angeles 51
Hong Kong 48
Des Moines 46
Catanzaro 41
Hanoi 36
Phoenix 35
Shanghai 28
Turku 28
São Paulo 27
New York 26
Rome 23
Washington 19
Boardman 18
Brooklyn 17
San Francisco 17
Guangzhou 16
Pune 15
Shenzhen 13
Johannesburg 12
Rio de Janeiro 12
Naples 11
Palermo 11
San Salvador 11
Tokyo 11
Curitiba 10
Montreal 10
Redmond 10
San José 10
Amsterdam 9
Chennai 9
Denver 9
Norwalk 9
Biên Hòa 8
Boston 8
Casoria 8
Guatemala City 8
Orem 8
San Nicola Manfredi 8
Toronto 8
Atlanta 7
Brasília 7
Cagliari 7
Haiphong 7
Olomouc 7
San Juan 7
Seattle 7
Bari 6
Catania 6
Chaguanas 6
Crotone 6
Guayaquil 6
Hanover 6
Jyväskylä 6
Messina 6
Montevideo 6
The Dalles 6
Weihai 6
Amman 5
Cairo 5
Charlotte 5
Columbus 5
Da Nang 5
Redwood City 5
San Mateo 5
Warsaw 5
Wuhan 5
Anagni 4
Aversa 4
Baghdad 4
Bogotá 4
Buenos Aires 4
Buffalo 4
Dongyang 4
Erbil 4
Heidesheim 4
Hải Dương 4
Istanbul 4
Jiaxing 4
Lima 4
Luni 4
Totale 4.918
Salva come PNG Salva come JPEG
Nome #
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 213
A Candidate multi-targeting approach to block the CD98hc oncoprotein 119
Mediterranean products as promising source of multi-target agents in the treatment of metabolic syndrome 119
A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine. 107
Molecular recognition of a carboxy pyridostatin towards G-quadruplex structures: why does it prefer RNA? 106
Abstract B122: The CD98hc oncoprotein as a target of new anticancer therapy 96
GBPM: applicazione al docking molecolare 96
Isolation and Functional Characterization of Peptide Agonists of PTPRJ, a Tyrosine Phosphatase Receptor Endowed with Tumor Suppressor Activity. 96
Ligand binding to telomeric G-quadruplex DNA investigated by funnel-metadynamics simulations 89
Back Cover: Hit Identification of a Novel Dual Binder for h-telo/c-myc G-Quadruplex by a Combination of Pharmacophore Structure-Based Virtual Screening and Docking Refinement (ChemMedChem 16/2016) 89
Discovery of PTPRJ Agonist Peptides That Effectively Inhibit in Vitro Cancer Cell Proliferation and Tube Formation. 89
A Computational pathway toward the rational design of azinomycin analogues 88
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity 84
In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold 83
Computer-based techniques for lead identification and optimization II: Advanced search methods 83
Chemioterapici antifungini 82
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses 82
The Mediterranean Diet as source of bioactive compounds with multi-targeting anti-cancer profile 81
Aryl ethynyl anthraquinones: a useful platform for targeting telomeric G-quadruplex structures 80
Identification and Characterization of New DNA G-Quadruplex Binders Selected by a Combination of Ligand and Structure-Based Virtual Screening Approaches 80
A Comparative Docking Strategy to Identify Polyphenolic Derivatives as Promising Antineoplastic Binders of G-quadruplex DNA c-myc and bcl-2 Sequences 77
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 75
SI113, a Specific Inhibitor of the Sgk1 Kinase Activity that Counteracts Cancer Cell Proliferation 75
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties 73
Hit Identification of a Novel Dual Binder for h-telo/c-myc G-Quadruplex by a Combination of Pharmacophore Structure-Based Virtual Screening and Docking Refinement 72
Molecular recognition studies of dasabuvir, tegobuvir, and setrobuvir against natural Hepatitis C Virus NS5B polymerase variants. 72
Characterization and Structural Analysis of Novel Mutations in HIV-1 Reverse Transcriptase Involved in the Regulation of Resistance to Non-Nucleoside Inhibitors 71
In Silico-Guided Rational Drug Design and Synthesis of Novel 4-(Thiophen-2-yl)butanamides as Potent and Selective TRPV1 Agonists 70
Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques 70
Identification of G-quadruplex DNA/RNA binders: Structure-based virtual screening and biophysical characterization 69
In Silico Identification of Piperidinyl-amine Derivatives as Novel Dual Binders of Oncogene c-myc/c-Kit G-quadruplexes 68
Characterization of the role of two additional HIV-1 reverse transcriptase mutations in the regulation of NNRTI resistance 68
CoMFA studies of non covalent monoamine oxidase inhibitors 68
Comparison of molecular dynamics simulations carried out on wild type and mutants of HIV-1 reverse transcriptase 68
Identification of New Natural DNA G-Quadruplex Binders Selected by a Structure-Based Virtual Screening Approach 67
A computer-assisted discovery of novel potential anti-obesity compounds as selective carbonic anhydrase VA inhibitors 67
An overview on olfaction in the biological, analytical, computational, and machine learning fields 67
In silico identification and biological evaluation of antioxidant food components endowed with IX and XII hCA inhibition 66
Folding intermediate states of the parallel human telomeric G-quadruplex DNA explored using Well-Tempered Metadynamics 66
Characterization and structural analysis of HIV-1 integrase conservation 65
Kaempferol as Selective Human MAO-A Inhibitor: Analytical Detection in Calabrian Red Wines, Biological and Molecular Modeling Studies 64
Multi-targeting bioactive compounds extracted from essential oils as kinase inhibitors 63
From Homology Modeling to the Hit Identification and Drug Repurposing: A Structure-Based Approach in the Discovery of Novel Potential Anti-Obesity Compounds 62
Comparison of Computational Methods in Docking Experiments of G-Quadruplex Binders 62
GBPM analysis of HIV-1 reverse transcriptase–DNA crystallographic complexes focused on the enzyme conserved regions of HAART-treated patients 62
Computer-based techniques for lead identification and optimization i: Basics 62
Natural products extracted from fungal species as new potential anti-cancer drugs: A structure-based drug repurposing approach targeting HDAC7 62
Structure-based virtual screening and molecular dynamics simulations of FDA-approved drugs targeting MALAT1 61
Identification and Structural Characterization of Novel Genetic Elements in HIV-1 - V3 Loop Regulating Co-Receptor Usage 61
Computational analysis of human immunodeficiency virus (HIV) type-1 reverse transcriptase crystallographic models based on significant conserved residues found in highly active antiretroviral therapy (HAART)-treated patients 61
Correction: Curcio et al. The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods. Pharmaceuticals 2024, 17, 620 60
Conformational studies and solvent-accessible surface area analysis of known selective DNA G-Quadruplex binders 60
The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods 60
Targeting SARS-CoV-2 Main Protease: A Successful Story Guided by an In Silico Drug Repurposing Approach 58
Identification of new G-quadruplex binders by combined virtual screening approaches. 58
Targeting multiple G-quadruplex–forming DNA sequences: Design, biophysical and biological evaluations of indolo-naphthyridine scaffold derivatives 58
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients 57
Indagine statistica sulla diffusione nell’Industria farmaceutica italiana di tecnologie computazionali avanzate orientate alla progettazione di nuovi farmaci 57
Hepatitis C Virus Genetic Variability and the Presence of NS5B Resistance-Associated Mutations as Natural Polymorphisms in Selected Genotypes Could Affect the Response to NS5B Inhibitors 57
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile 56
Hybrid ligand-alkylating agents targeting telomeric G-quadruplex structures 56
Design, Synthesis, and Evaluation of New Tripeptides as COX-2 Inhibitors 56
Metodi computazionali e nutraceutica 56
Hit Identification and Functional Validation of Novel Dual Inhibitors of HDAC8 and Tubulin Identified by Combining Docking and Molecular Dynamics Simulations 55
Dinamica molecolare di complessi della proteasi di HIV-1: influenza di mutazioni associate a resistenza sulla ricognizione molecolare 55
Composti per il G-quadruplex a struttura naftilimmidica 55
Computer-based techniques for lead identification and optimization I: Basics 54
Hit identification of novel small molecules interfering with MALAT1 triplex by a structure-based virtual screening 54
Progettazione razionale di agenti bisalchilanti del DNA analoghi delle azinomicine 54
Molecular and structural aspects of clinically relevant mutations related to the approved non-nucleoside inhibitors of HIV-1 reverse transcriptase 53
Computational analysis of HIV-1 reverse transcriptase complexes 52
Studi computazionali su modelli di Trascrittasi Inversa del virus HIV 52
Structural Modeling of New Polymorphism Clusters of HCV Polymerase Isolated from Direct-Acting Antiviral Naïve Patients: Focus on Dasabuvir and Setrobuvir Binding Affinity 51
Docking e virtual screening su composti naturali: esempi su quercitina e cucurbitacina 50
Design and Synthesis of a (N-Alkylaminoalkyl-Substituted) Arylalkenylamide Drug Discovery Library 50
Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 Usage 49
High-throughput lipophilicity screening of opioid-like analgesics: validation of computational methods by means of RP-HPLC analysis 49
Conformation and stability of intramolecular telomeric g-quadruplexes: sequence effects in the loops 49
Conformational analysis of bioactive conformations in the drug discovery process 49
Targeting unimolecular G-quadruplex nucleic acids: a new paradigm for the drug discovery? 49
Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control 49
Molecular interaction fields in drug discovery: recent advances and future perspectives 48
New Resistance Mutations to Nucleoside Reverse Transcriptase Inhibitors at Codon 184 of HIV-1 Reverse Transcriptase (M184L and M184T). 48
Design and Synthesis of New Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channel Modulators: Identification, Molecular Modeling Analysis, and Pharmacological Characterization of the N-(4-Hydroxy-3-methoxybenzyl)-4-(thiophen-2-yl)butanamide, a Small Molecule Endowed with Agonist TRPV1 Activity and Protective Effects against Oxidative Stress 47
Computational study on DNA G-quadruplex binding compounds 47
Tetraplex DNA specific ligands based on the fluorenone-carboxamide scaffold 47
Progettazione razionale e sintesi di prodotti di semplificazione molecolare delle azinomicine 47
Dependence of DNA sequence selectivity and cell cytotoxicity on azinomycin A and B epoxyamide stereochemistry 46
Structure-Based Virtual Screening of Novel Natural Alkaloid Derivatives as Potential Binders of h-telo and c-myc DNA G-Quadruplex Conformations 46
Docking comparativo nello sviluppo di ligandi per il DNA G-quadruplex 46
Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir containing regimens 46
Pathway involving the N155H mutation in HIV-1 integrase leads to dolutegravir resistance 46
Mediterranean products as promising source of multi-target agents in the treatment of metabolic syndrome 46
Targeting non-coding RNAs: Perspectives and challenges of in-silico approaches 44
Docking studies of Lopinavir, Atazanavir and Darunavir binding modes to HIV-1 protease mutants 44
Effect of maraviroc on non-R5 tropic HIV-1: refined analysis of subjects from the phase IIb study A4001029 44
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors 44
Docking comparativo per lo sviluppo di ligandi per il DNA G-Quadruplex 44
The polymorphisms of DNA g-quadruplex investigated by docking experiments with telomestatin enantiomers 44
Molecular dynamics and free energy studies on the wild-type and mutated HIV-1 protease complexed with four approved drugs: mechanism of binding and drug resistance 43
Totale 6.521
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.740
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.740
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022315 0 0 0 64 23 6 14 80 22 33 69 4
2022/2023997 253 48 46 71 111 72 9 70 154 58 81 24
2023/2024505 70 54 46 30 33 151 12 45 4 21 16 23
2024/20251.688 202 143 64 57 115 198 91 66 218 119 151 264
2025/20263.521 169 352 638 483 301 152 357 220 447 247 109 46
2026/2027812 44 143 306 319 0 0 0 0 0 0 0 0
Totale 8.170